Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 156034, 7 pages
http://dx.doi.org/10.1155/2014/156034
Research Article

Breast Carcinoma Progression and Tumour Vascular Markers Related to Apoptotic Mechanisms

1Department of Medical and Clinical Biochemistry and LABMED, Faculty of Medicine, P. J. Šafárik University in Košice, Trieda SNP 1, 040 11 Košice, Slovakia
2Department of Histology and Embryology, Faculty of Medicine, P. J. Šafárik University in Košice, Šrobárova 2, 040 11 Košice, Slovakia
32nd Department of Gynecology and Obstetrics, Faculty of Medicine, P. J. Šafárik University in Košice, Rastislavova 43, 040 11 Košice, Slovakia
4International Clinical Research Center, St. Anne’s University Hospital, Pekařská 53, 656 91 Brno, Czech Republic

Received 31 October 2013; Accepted 3 January 2014; Published 18 February 2014

Academic Editor: Ralf Lichtinghagen

Copyright © 2014 Miroslava Bilecova-Rabajdova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sarkar and M. Mandal, “Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer,” Breast Cancer, vol. 3, no. 1, pp. 47–60, 2009. View at Google Scholar · View at Scopus
  2. W. Liu, S. A. Ahmad, N. Reinmuth et al., “Endothelial cell survival and apoptosis in the tumor vasculature,” Apoptosis, vol. 5, no. 4, pp. 323–328, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Seaman, J. Stevens, M. Y. Yang, D. Logsdon, C. Graff-Cherry, and B. St. Croix, “Genes that distinguish physiological and pathological angiogenesis,” Cancer Cell, vol. 11, no. 6, pp. 539–554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. MacFadyen, O. Haworth, D. Roberston et al., “Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium,” FEBS Letters, vol. 579, no. 12, pp. 2569–2575, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Buckanovich, D. Sasaroli, A. O'Brien-Jenkins et al., “Tumor vascular proteins as biomarkers in ovarian cancer,” Journal of Clinical Oncology, vol. 25, no. 7, pp. 852–861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. W. Fesik, “Promoting apoptosis as a strategy for cancer drug discovery,” Nature Reviews Cancer, vol. 5, no. 11, pp. 876–885, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Vouyiouklis, H. Werner, I. R. Griffiths, G. J. Stewart, K. Armin-Nave, and C. E. Thomson, “Molecular cloning and transfection studies of M6b-2, a novel splice variant of a member of the PLP-DM20/M6 gene family,” Journal of Neuroscience Research, vol. 52, pp. 633–640, 1998. View at Google Scholar
  8. D.-F. Wu, T. Koch, Y.-J. Liang et al., “Membrane glycoprotein M6a interacts with the μ-opioid receptor and facilitates receptor endocytosis and recycling,” Journal of Biological Chemistry, vol. 282, no. 30, pp. 22239–22247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. N. L. Nadon, S. Miller, K. Draeger, and M. Salvaggio, “Myelin proteolipid DM20: evidence for function independent of myelination,” International Journal of Developmental Neuroscience, vol. 15, no. 3, pp. 285–293, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. A. W. Fjorback, H. K. Müller, and O. Wiborg, “Membrane glycoprotein M6B interacts with the human serotonin transporter,” Journal of Molecular Neuroscience, vol. 37, no. 3, pp. 191–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. V. P. Pai and N. D. Horseman, “Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways,” Journal of Biological Chemistry, vol. 283, no. 45, pp. 30901–30910, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. V. P. Pai, A. M. Marshall, L. L. Hernandez, A. R. Buckley, and N. D. Horseman, “Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival,” Breast Cancer Research, vol. 11, no. 6, article R81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. Guicciardi and G. J. Gores, “Life and death by death receptors,” The FASEB Journal, vol. 23, no. 6, pp. 1625–1637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Benschop, T. Wei, and S. Na, “Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6,” Advances in Experimental Medicine and Biology, vol. 647, pp. 186–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Zeng, T. Li, D. C. Xu et al., “Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax protein,” The Journal of Biological Chemistry, vol. 287, pp. 29125–29133, 2012. View at Google Scholar
  16. E. Naik, L. A. O'Reilly, M.-L. Asselin-Labat et al., “Destruction of tumor vasculature and abated tumor growth upon VEGF blockade is driven by proapoptotic protein Bim in endothelial cells,” Journal of Experimental Medicine, vol. 208, no. 7, pp. 1351–1358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-P. Gerber, V. Dixit, and N. Ferrara, “Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells,” Journal of Biological Chemistry, vol. 273, no. 21, pp. 13313–13316, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Gupta, S. Kshirsagar, W. Li et al., “VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling,” Experimental Cell Research, vol. 247, no. 2, pp. 495–504, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. L. A. Tartaglia and D. V. Goeddel, “Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor,” Journal of Biological Chemistry, vol. 267, no. 7, pp. 4304–4307, 1992. View at Google Scholar · View at Scopus
  20. A. Ashkenazi, P. Holland, and S. G. Eckhardt, “Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL),” Journal of Clinical Oncology, vol. 26, no. 21, pp. 3621–3630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. S. Herbst, R. Kurzrock, D. S. Hong et al., “A first-in-human study of conatumumab in adult patients with advanced solid tumors,” Clinical Cancer Research, vol. 16, no. 23, pp. 5883–5891, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Kasof, J. J. Lu, D. Liu et al., “Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB,” Oncogene, vol. 20, no. 55, pp. 7965–7975, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Schulze-Osthoff, D. Ferrari, M. Los, S. Wesselborg, and M. E. Peter, “Apoptosis signaling by death receptors,” European Journal of Biochemistry, vol. 254, no. 3, pp. 439–459, 1998. View at Google Scholar · View at Scopus
  24. E. M. Tam, C. J. Morrison, Y. I. Wu, M. S. Stack, and C. M. Overall, “Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 18, pp. 6917–6922, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Têtu, J. Brisson, C. S. Wang et al., “The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis,” Breast Cancer Research, vol. 8, no. 3, article R28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Yang, C. Mooney, G. Spahlinger et al., “DR6 as a diagnostic and predictive biomarker in adult sarcoma,” PLoS ONE, vol. 7, no. 5, Article ID e36525, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Y. Lin, J.-F. Li, L. Gnatovskiy et al., “Macrophages regulate the angiogenic switch in a mouse model of breast cancer,” Cancer Research, vol. 66, no. 23, pp. 11238–11246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. Houghton, J. L. Grisolano, M. L. Baumann et al., “Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases,” Cancer Research, vol. 66, no. 12, pp. 6149–6155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Dong, R. Kumar, X. Yang, and I. J. Fidler, “Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma,” Cell, vol. 88, no. 6, pp. 801–810, 1997. View at Publisher · View at Google Scholar · View at Scopus